YOLFTbeta
Medios AG

Medios AG

ILM1 · XETRA · Healthcare / Medical Distribution

10.88EUR-0.28 (-2.51%)

Price History

Full chart

Market Stats

Previous Close11.16
Open11.16
Day Range10.66 – 11.18
52-Week Range9.98 – 17.44
Volume105.13K
Market Cap264.24M
P/E (TTM)22.52
Forward P/E7.94
EPS0.46
Dividend Yield0.00%
Beta1.30
50-Day Avg10.89
200-Day Avg13.17

About

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG was founded in 2015 and is headquartered in Berlin, Germany.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Thomas Meier
  • Employees989
  • HeadquartersHeidestrasse 9, Berlin, Germany, 10557, Germany
  • Websitehttps://www.medios.ag

Leadership

  • Mr. Christoph PrusseitChief Business Officer of Germany & Member of Executive Board · b. 1988
  • Mr. Constantijn van RietschotenChief Business Officer of International and Member of Executive Board · b. 1970
  • Mr. Thomas MeierCEO & Member of Executive Board · b. 1968
  • Mr. Stefan BauerreisCFO & Member of the Executive Board · b. 1972
  • Ms. Katrin Yvonne NeufferDirector Investor Relations & Communications · b. 1977

Financials

Income Statement

Currency: EUR2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.04M1.38M35.22K326.114.48K134.74133.21M253.64M327.83M516.80M626.54M1.36B1.61B1.78B1.88B2.08B
Growth (%)-+32.52%-97.44%-99.07%+1274.92%-96.99%+98865053.63%+90.40%+29.25%+57.64%+21.23%+116.65%+18.67%+10.80%+5.51%+10.39%
Cost of Revenue-297.83K1.09M-68.97K2.00K56.69M125.78M236.27M304.70M482.77M588.96M1.29B1.50B1.68B1.73B1.99B
Gross Profit1.34M287.61K35.22K326.114.48K-56.69M7.43M17.37M23.13M34.03M37.58M68.48M106.87M108.63M151.46M91.93M
Gross Margin128.70%20.92%100.00%100.00%100.00%-42075749.78%5.58%6.85%7.06%6.58%6.00%5.04%6.63%6.09%8.04%4.42%
Operating Expense-1.10M257.76K239.01K165.49K37.62K-56.53M8.25M10.57M15.73M19.64M28.04M53.22M77.90M77.25M119.80M50.20M
Operating Income2.44M29.85K-203.79K-165.16K-33.13K-159.34K-821.49K6.80M7.40M14.39M9.54M15.26M28.97M31.37M31.66M41.73M
Operating Margin234.95%2.17%-578.54%-50645.58%-738.99%-118257.76%-0.62%2.68%2.26%2.78%1.52%1.12%1.80%1.76%1.68%2.01%
EBITDA-165.16K59.38K-189.89K-149.76K-32.86K1.10M-712.00K7.29M8.56M16.40M13.12M34.68M51.33M52.82M64.00M79.59M
EBITDA Margin-15.92%4.32%-539.09%-45922.23%-732.83%817950.87%-0.53%2.87%2.61%3.17%2.09%2.55%3.19%2.96%3.40%3.83%
Net Income-60.31K-203.79K-165.16K-33.17K-160.86K-3.17M4.13M4.33M9.76M5.53M7.40M18.33M18.81M12.55M15.37M
Net Income Margin-4.39%-578.54%-50645.54%-739.68%-119388.59%-2.38%1.63%1.32%1.89%0.88%0.55%1.14%1.05%0.67%0.74%
R&D--------90.00K428.00K------
R&D as % of Total Revenue--------0.03%0.08%------
Interest Expense1.28M9.63K11.12K98.42276.21.52K1.29M96.49K35.06K193.90K671.00K1.73M1.26M2.41M10.86M19.12M
Interest Expense % of Total Revenue123.31%0.70%31.56%30.18%6.16%1130.84%0.97%0.04%0.01%0.04%0.11%0.13%0.08%0.13%0.58%0.92%

Balance Sheet

Currency: EUR2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets4.46M859.39K657.48K441.11K234.35K89.78K509.21K47.86M61.71M98.42M116.57M194.54M524.14M575.96M594.75M934.36M903.04M
Total Liabilities-2.92M518.32K280.72K268.14K226.54K89.78K185.43K13.76M16.03M27.92M34.94M52.11M129.98M127.91M125.95M424.17M388.82M
Total Equity921.00K341.07K376.75K172.97K7.81K-323.78K32.12M45.68M70.50M81.63M142.43M394.16M448.05M468.81M510.19M514.22M
Cash58.00K55.62K12.06K180.638.41K20.83K501.19K17.09M16.68M11.77M15.62M19.79M168.43M79.21M71.04M106.00M81.84M
Total Debt256.00K253.45K128.87K------203.17K6.24M19.23M49.71M17.93M17.15M238.37M188.89M
Net Debt198.00K197.83K116.81K-180.63-8.41K-20.83K-501.19K-17.09M-16.68M-11.57M-9.38M-562.00K-118.72M-61.58M-53.89M132.37M107.05M

Cash Flow

Currency: EUR2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.70K-80.60K21.22K103.36K13.30K-99.64K-1.58M816.00K-3.14M-449.29K-38.12M61.52M37.12M16.41M73.67M43.00M
Investing Cash Flow21.30K156.50K-123.49-123.37--119.00K-371.00K-7.18M-1.81M2.19M-5.88M17.36M-86.54M-16.57M-222.28M-4.78M
Financing Cash Flow-1.40K-119.40K22.09K-94.08K-880580.00K17.73M5.96M-171.02K-662.79K51.14M69.76M-39.80M-8.01M183.80M-62.60M
Capital Expenditure17.40K3.50K123.49208.370119.00K372.00K5.34M1.82M2.09M4.86M12.82M5.06M1.21M6.31M6.07M
Free Cash Flow-21.10K-84.10K21.10K103.15K13.30K-218.64K-1.95M-4.53M-4.96M-2.54M-42.98M48.70M32.06M15.14M67.36M36.94M
Dividends Paid----------1.79M2.76M----
FCF to OCF570.27%104.34%99.42%99.80%100.00%219.43%123.51%-554.53%158.19%565.03%112.76%79.16%86.36%92.31%91.44%85.90%
Dividend Paid to FCF-----------4.16%5.67%----

Earnings

Report DateAug 30, 2017Apr 18, 2018Sep 19, 2018Nov 28, 2018Apr 17, 2019Aug 28, 2019Nov 27, 2019Feb 26, 2020Jun 3, 2020Sep 2, 2020Dec 2, 2020Mar 3, 2021May 11, 2021Aug 12, 2021Nov 9, 2021Mar 29, 2022May 11, 2022Aug 11, 2022Nov 10, 2022Mar 30, 2023May 11, 2023Aug 14, 2023Nov 14, 2023Apr 25, 2024Aug 12, 2024Nov 12, 2024Mar 25, 2025May 13, 2025Aug 13, 2025Nov 11, 2025May 12, 2026Nov 10, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.00----0.22-0.240.270.200.230.280.170.180.000.000.00-0.000.00-
EPS Actual0.210.120.110.000.200.270.000.380.150.150.070.070.140.170.170.170.210.210.250.110.200.190.280.100.100.000.250.250.250.290.00-
Surprise-----------------4.55%-4.17%-59.26%1.45%-18.96%0.00%-41.18%-44.44%-------
Timing---------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-After-hours---After-hours-After-hoursPre-market

Key Statistics & Ratios

Market Cap264.24M
Enterprise Value362.78M
Trailing P/E22.52
Forward P/E7.94
PEG Ratio0.00
Price / Sales0.12
Price / Book0.49
EPS0.46
Book Value21.35
Revenue (TTM)2.16B
Gross Profit (TTM)198.50M
EBITDA69.70M
Profit Margin0.52%
Operating Margin1.64%
Return on Equity2.14%
Return on Assets2.64%
Shares Outstanding25.51M
Shares Float14.33M
Beta1.30
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 19, 20121:4